Stage 0 cancer, known as carcinoma in situ, marks the earliest stage of cancer development. Abnormal cells are present but ...

Approved targeted drugs for HER2 -mutant NSCLC include trastuzumab deruxtecan (T-DXd, Enhertu) -- which is highly effective ...

An agency within the Department of Health and Human Services has awarded Carnegie Mellon University researchers $26.7 million to develop a single at-home cancer screening system using synthetic ...

In a world buzzing with health information, myths relating to breast and oral cancers can incite undue alarm. In the worst ...

FX-909, a first-in-class investigational oral small molecule inhibitor of peroxisome proliferator-activated receptor gamma ...

Stage 0 cancer, or carcinoma in situ, represents the earliest detectable phase where abnormal cells are confined to their ...

Ovarian cancer has been described as a “silent killer” because it often goes unnoticed until it reaches an advanced stage, according to Obstetrician-Gynecologist, Professor Samuel Antwi Oppong.

Neoadjuvant Enhertu then THP improved pathological complete response rate in patients with high-risk, HER2-positive early ...

A healthy mouth is a window to a healthy body. Oral hygiene is not merely about having a bright smile — it is deeply linked ...

we're able to spot cancers early, and educate our patients so that they know when to spot when something's not normal." Fourth-year dental student Isabelle Adams has been learning how to spot the ...

Brain tumours are rare, but their early signs are easy to mistake for stress, tiredness or the menopause. Researchers explain ...